Outcome prognostic factors in inoperable malignant bowel obstruction

被引:9
|
作者
Romeo, Margarita [1 ,2 ]
de los LLanos Gil, Maria [1 ]
Cuadra Urteaga, Jose Luis [1 ]
Vila, Laia [1 ]
Ahlal, Sara [1 ]
Indacochea, Alberto [1 ,3 ]
Pardo, Nuria [1 ,4 ]
Radua, Joaquim [5 ,6 ]
Font, Albert [1 ]
Tuca, Albert [7 ]
机构
[1] Inst Catala Oncol, Dept Med Oncol, Carretera Canyet S-N, Badalona 08916, Spain
[2] Univ Autonoma Barcelona, Barcelona, Spain
[3] Vall dHebron Inst Recerca, CRG, Barcelona, Spain
[4] Hosp Valle De Hebron, Vall dHebron Inst Oncol, Dept Med Oncol, Barcelona, Spain
[5] FIDMAG Germanes Hosp CIBERSAM, St Boi De Llobregat, Spain
[6] Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, Solna, Sweden
[7] Hosp Clin Barcelona, Dept Med Oncol, Support Care Canc Unit, Barcelona, Spain
关键词
Malignant bowel obstruction; Octreotide; Hyoscine butylbromide; Prognostic factors; SCOPOLAMINE BUTYLBROMIDE; DOUBLE-BLIND; PHARMACOLOGICAL-TREATMENT; HYOSCINE BUTYLBROMIDE; RANDOMIZED-TRIAL; SYMPTOM CONTROL; CLINICAL-TRIAL; OCTREOTIDE; CANCER; MANAGEMENT;
D O I
10.1007/s00520-016-3299-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Inoperable malignant bowel obstruction (MBO), a severe complication of peritoneal carcinomatosis, has a low desobstruction rate (30-40 %) and end-of-life decision-making is hampered by the lack of known prognostic factors. This study aimed to explore prognostic factors for desobstruction in MBO. All patients with inoperable MBO admitted in our large oncology hospital between 2010 and 2013 were treated following a clinical protocol based on antiemetics, steroids and two antisecretories, octreotide, and hyoscine butylbromide. Two prognostic factor analyses using logistic regressions were performed, one based on data from day 1 of admission and the other on data from day 8. Forty-five patients were included. Frequency of desobstruction was 48.9 %. In the analysis of prognostic factors on day 1, MBO episodes derived from functional physiopathologic mechanisms (vs. mechanic or mixed) were more prone to resolve (p < 0.001 corrected for multiple comparisons). Considering patients alive with persistent obstruction on day 8, a better clinical condition was the variable more associated with desobstruction, but without statistical significance after correction for multiple comparisons. A functional physiopathologic mechanism of MBO development may be an early prognostic factor for desobstruction. A high proportion of desobstruction was observed, suggesting that the combination of antisecretories with different mechanism of action warrants further investigation.
引用
收藏
页码:4577 / 4586
页数:10
相关论文
共 50 条
  • [1] Outcome prognostic factors in inoperable malignant bowel obstruction
    Margarita Romeo
    Maria de los LLanos Gil
    José Luís Cuadra Urteaga
    Laia Vilà
    Sara Ahlal
    Alberto Indacochea
    Núria Pardo
    Joaquim Radua
    Albert Font
    Albert Tuca
    Supportive Care in Cancer, 2016, 24 : 4577 - 4586
  • [2] Surgical and Conservative Management of Malignant Bowel Obstruction: Outcome and Prognostic Factors
    Yu, Kaiying
    Liu, Lihui
    Zhang, Xiaowei
    Zhang, Zhanzhi
    Rao, Benqiang
    Chen, Yongbing
    Li, Suyun
    Shi, Hanping
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 7797 - 7803
  • [3] Chemonaivete in inoperable malignant bowel obstruction
    Boutayeb, Saber
    El Ghissassi, Ibrahim
    Mrabti, Hind
    Errihani, Hassan
    CURRENT ONCOLOGY, 2017, 24 (01) : E75 - E75
  • [4] Development of a Core Outcome Set for the research and assessment of inoperable malignant bowel obstruction
    Bravington, Alison
    Obita, George
    Baddeley, Elin
    Johnson, Miriam J.
    Murtagh, Fliss E. M.
    Currow, David C.
    Boland, Elaine G.
    Nelson, Annmarie
    Seddon, Kathy
    Oliver, Alfred
    Noble, Simon I. R.
    Boland, Jason W.
    PLOS ONE, 2023, 18 (08):
  • [5] Medical Management of Inoperable Malignant Bowel Obstruction
    Huang, Xiaoyan
    Xue, Jing
    Gao, Min
    Qin, Qiyuan
    Ma, Tenghui
    Li, Xiaoyan
    Wang, Hui
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (09) : 1134 - 1145
  • [6] Surgical Management of Malignant Intestinal Obstruction: Outcome and Prognostic Factors
    Bento de Sousa, Jorge Henrique
    Bianchi, Edno Tales
    Tustumi, Francisco
    Leonardi, Paulo Cesar
    Ribeiro Junior, Ulysses
    Ceconello, Ivan
    CHIRURGIA, 2019, 114 (03) : 343 - 351
  • [7] Prognostic Factors for Surgical Failure in Malignant Bowel Obstruction and Peritoneal Carcinomatosis
    Lodoli, Claudio
    Covino, Marcello
    Attalla El Halabieh, Miriam
    Santullo, Francesco
    Di Giorgio, Andrea
    Abatini, Carlo
    Rotolo, Stefano
    Rodolfino, Elena
    Giovinazzo, Francesco
    Fagotti, Anna
    Scambia, Giovanni
    Franceschi, Francesco
    Pacelli, Fabio
    FRONTIERS IN SURGERY, 2021, 8
  • [8] Home parenteral nutrition for people with inoperable malignant bowel obstruction
    Sowerbutts, Anne Marie
    Lal, Simon
    Sremanakova, Jana
    Clamp, Andrew
    Todd, Chris
    Jayson, Gordon C.
    Teubner, Antje
    Raftery, Anne-Marie
    Sutton, Eileen J.
    Hardy, Lisa
    Burden, Sorrel
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (08):
  • [9] Medical treatment for inoperable malignant bowel obstruction: A qualitative systematic review
    Mercadante, Sebastiano
    Casuccio, Alessandra
    Mangione, Salvatore
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2007, 33 (02) : 217 - 223
  • [10] HOME PARENTERAL-NUTRITION FOR PATIENTS WITH INOPERABLE MALIGNANT BOWEL OBSTRUCTION
    AUGUST, DA
    THORN, D
    FISHER, RL
    WELCHEK, CM
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1991, 15 (03) : 323 - 327